Propranolol Injection is a highly effective beta-blocker used primarily in the management and treatment of cardiovascular and neurological conditions. This injectable formulation of Propranolol offers rapid onset of action for acute treatment scenarios. It is indicated for Angina pectoris to reduce chest pain, control Arrhythmias by regulating heartbeat, and manage Hypertension by lowering elevated blood pressure levels. Additionally, it is employed in myocardial infarction (heart attack) management to improve patient outcomes. Propranolol Injection is also used to alleviate symptoms of Anxiety and Tremors, treat glaucoma by lowering intraocular pressure, and manage Heart Failure by improving cardiac function. Its preventive role in migraine attacks significantly reduces the frequency and severity of migraine headaches. Furthermore, Propranolol is utilized in the treatment of Pheochromocytoma, a rare adrenal gland tumor, by controlling catecholamine-induced symptoms. The injectable form ensures precise dosing and swift therapeutic effect, suitable for hospital and clinical settings requiring immediate drug action. The formulation complies with pharmaceutical standards for parenteral administration, ensuring sterility and safety. This product is ideal for healthcare providers seeking an efficient cardiovascular and neurological therapeutic agent for critical care and chronic condition management.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Propranolol Hydrochloride |
| Formulation | Sterile injectable solution |
| Indications | Angina, Arrhythmia, Heart Attack, Hypertension, Anxiety, Tremors, Glaucoma, Heart Failure, Migraine Prevention, Pheochromocytoma |
| Route of Administration | Intravenous/Intramuscular injection |
| Onset of Action | Rapid |
| Therapeutic Class | Non-selective beta-adrenergic blocker |
| Dosage Forms Available | Multiple concentrations available for titration |
| Packaging | Sterile ampoules/vials |
| Storage Conditions | Store below 25°C, protect from light |
| Shelf Life | Typically 2 years from manufacture date |
| Attributes | Description |
|---|---|
| Molecular Formula | C16H21NO2 · HCl |
| Molecular Weight | 295.8 g/mol |
| pH | Between 3 and 5 |
| Appearance | Clear, colorless to slightly yellow solution |
| Dosage Strength | 10 mg/mL, 1 mg/mL or as per manufacturer specification |
| Sterility | Aseptic and pyrogen-free |
| Pharmacokinetics | Rapid absorption, hepatic metabolism |
| Packaging Size | 1 mL, 2 mL, or 5 mL ampoules/vials |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Propranolol Injection is primarily indicated for treatment of angina, arrhythmia, hypertension, heart attack management, anxiety, tremors, glaucoma, heart failure, migraine prevention, and pheochromocytoma.
Propranolol Injection is administered via intravenous or intramuscular routes, allowing rapid onset of action suitable for urgent cardiovascular and neurological treatment scenarios.
Yes, Propranolol Injection is effective in preventing migraine attacks by reducing their frequency and severity in patients with a history of migraines.
Propranolol Injection is available in sterile injectable solutions in concentrations such as 1 mg/mL and 10 mg/mL, typically packaged in 1 mL, 2 mL, or 5 mL ampoules or vials.
Propranolol Injection should be stored below 25°C, protected from light, and kept in its original packaging to maintain sterility and effectiveness.
Yes, Propranolol Injection is used to treat glaucoma by lowering intraocular pressure, but administration should be under strict medical supervision.
Country Of Origin: India
Propranolol is used in the treatment of Angina (heart-related chest pain), Arrhythmia, heart attack, Hypertension (high blood pressure), Anxiety, Tremors, glaucoma, Heart Failure, migraine, Prevention of migraine and Pheochromocytoma.
